Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese Participants”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03922633
What this trial is testing

A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants

Who this might be right for
Healthy Male Participants
EA Pharma Co., Ltd. 24
Early research (Phase 1)Study completedNCT04133116
What this trial is testing

LY3471851 in Healthy Participants

Who this might be right for
Healthy
Nektar Therapeutics 36
Early research (Phase 1)Study completedNCT01569126
What this trial is testing

LY110140 in Healthy Japanese Male Participants

Who this might be right for
Healthy Volunteer
Eli Lilly and Company 56
Early research (Phase 1)Study completedNCT05440136
What this trial is testing

A Safety Study of LY3462817 in Healthy Japanese and Non-Japanese Participants

Who this might be right for
Healthy
Eli Lilly and Company 33
Early research (Phase 1)Study completedNCT05037409
What this trial is testing

Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy Participants

Who this might be right for
Healthy
Pfizer 13
Early research (Phase 1)Study completedNCT06868082
What this trial is testing

Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants

Who this might be right for
Healthy
Uniquity One (UNI) 32
Early research (Phase 1)Study completedNCT05877222
What this trial is testing

Trial to Investigate the Biological Equivalence of 5 × 10 mg Tablets and 2 × 25 mg Tablets of Daridorexant in Healthy Male and Female Japanese Participants

Who this might be right for
Healthy
Idorsia Pharmaceuticals Ltd. 38
Early research (Phase 1)Study completedNCT07361354
What this trial is testing

An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)

Who this might be right for
Healthy ParticipantsPharmacokinetic Study
Angitia Incorporated Limited 28
Early research (Phase 1)Study completedNCT02398591
What this trial is testing

Investigate Safety, Tolerability, and Pharmacokinetics of JNJ 53718678 in Healthy Japanese Adult Participants

Who this might be right for
Healthy
Janssen Sciences Ireland UC 24
Early research (Phase 1)Study completedNCT02418559
What this trial is testing

Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-63623872 in Healthy Japanese Adult Participants

Who this might be right for
Healthy
Janssen Infectious Diseases BVBA 24
Early research (Phase 1)Active Not RecruitingNCT07514260
What this trial is testing

Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity.

Who this might be right for
Healthy Volunteer
AbbVie 24
Early research (Phase 1)Study completedNCT04791332
What this trial is testing

JNJ-67953964 in Healthy Japanese Adult Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 30
Early research (Phase 1)Study completedNCT04878471
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASP5354 in Healthy Adult Japanese Male Participants

Who this might be right for
Healthy Volunteers
Astellas Pharma Inc 12
Early research (Phase 1)Not Yet RecruitingNCT07801300
What this trial is testing

LY5625575 in Healthy Participants and in Participants With Inflammation (Elevated C-Reactive Protein)

Who this might be right for
Healthy VolunteersC-Reactive Protein
Eli Lilly and Company 204
Early research (Phase 1)Study completedNCT02008279
What this trial is testing

A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 40
Early research (Phase 1)Study completedNCT01809353
What this trial is testing

To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 32
Early research (Phase 1)Study completedNCT05806359
What this trial is testing

Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 33
Early research (Phase 1)Study completedNCT02821858
What this trial is testing

Study to Investigate the Pharmacokinetics, Safety and Tolerability of Odalasvir and AL-335 in Healthy Japanese Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 40
Early research (Phase 1)Study completedNCT05315947
What this trial is testing

Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Male Japanese Study Participants

Who this might be right for
Healthy Study Participants
UCB Biopharma SRL 24
Early research (Phase 1)Study completedNCT01618916
What this trial is testing

LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) Cholesterol

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 51
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation